Hester Biosciences Ltd share price logo

Hester Biosciences Ltd Share Price

(HESTERBIO)

Check the latest share price of Hester Biosciences Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹1768.61.2%

as on 04:01PM, 13 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Hester Biosciences Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,732.7
    Day's Price Range
    ₹1,795
  • 52 Week's Low

    52 Week's High

    ₹1,242.95
    52-Week Price Range
    ₹3,379
1 Month Return+ 0.84 %
3 Month Return+ 0.43 %
1 Year Return+ 1.34 %
3 Year Return-25.85 %
5 Year Return+ 55.13 %
Previous Close₹1,747.60
Open₹1,749.00
Volume4,563.00
Upper Circuit₹2,097.10
Lower Circuit₹1,398.10

Hester Biosciences Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹1,486.66 Cr

Return on Equity (ROE)

8.98

PE Ratio (TTM)

51.57

Return on capital employed (ROCE)

8.51

Industry PE ratio

53.64

Beta (LTM)

0.81

P/B Ratio

3.78

Dividend Yield

0.43

PEG Ratio

5.73

Quarterly Earnings Growth YOY

-75.94

EPS (TTM)

24.88

Sector

Pharmaceuticals

Book Value

343

Technical Analysis

How to invest in Hester Biosciences Ltd

Investing in Hester Biosciences Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Hester Biosciences Ltd or HESTERBIO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Hester Biosciences Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Hester Biosciences Ltd with just a few clicks!

Hester Biosciences Ltd Stock's Interest Amongst Investors

-72%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Search interest for Hester Biosciences Ltd Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Hester Biosciences Ltd Valuation

Track how the P/E of Hester Biosciences Ltd has moved over time to understand valuation trends.

Hester Biosciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (19.52x)

March 23, 2020

Today (51.57x)

May 12, 2025

Industry (53.64x)

May 12, 2025

Highest (124.52x)

July 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 51.57x

Analysts Forecast on Hester Biosciences Ltd

Get share price movements and forecasts by analysts on Hester Biosciences Ltd.

Excluding Excise Duty and Other Income, represents Net Revenue

Hester Biosciences Ltd revenue growth forecast

Expected growth rate Q1, FY2023:0.94%

Forecast

Actual

Source: S&P Global Market Intelligence

Hester Biosciences Ltd Financials

Get the annual and quarterly financial summary of Hester Biosciences Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue

(in ₹ Cr)

79 (0%)82 (4%)84 (2%)63 (24%)82 (30%)
Net Income

(in ₹ Cr)

6 (0%)7 (17%)8 (12%)11 (36%)2 (86%)
Net Profit Margin8.07% (0%)9.10% (13%)10.03% (10%)18.05% (80%)1.88% (90%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

282 (0%)425 (50%)547 (29%)551 (1%)
Total Liabilities

(in ₹ Cr)

45 (0%)156 (250%)254 (62%)238 (6%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

26 (0%)41 (59%)16 (61%)33 (110%)43 (28%)

Hester Biosciences Ltd Index Inclusions

BSE Healthcare

₹41,998.59

0.96 (399.3%)

BSE Small-Cap

₹49,176.68

0.99 (482.93%)

Hester Biosciences Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Hester Biosciences Ltd.

  • Hester Biosciences Ltd Earnings Results

    Hester Biosciences Ltd’s net profit fell -73.94% since last year same period to ₹1.29Cr in the Q4 2024-2025. On a quarterly growth basis, Hester Biosciences Ltd has generated -88.94% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Hester Biosciences Ltd Dividends May,2024

    In the quarter ending March 2024, Hester Biosciences Ltd has declared dividend of ₹6 - translating a dividend yield of 0.80%.

    Read More about Dividends

Hester Biosciences Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Hester Biosciences Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
53.73%
0.00
Foreign Institutions
0.87%
0.00
Mutual Funds
0%
0.00
Retail Investors
45.38%
0.00
Others
0.02%
0.00

Hester Biosciences Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Hester Biosciences Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,486.6611.03%0.6921304
NA122.69100.86%0.501495
NA70.0394.93%2.0014502
NA105.1771.57%0.509188
NA50.0342.59%0.50167

Hester Biosciences Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Hester Biosciences Ltd.

  • Hester Biosciences Reports Significant Profit Decline - 09 May, 2025

    Hester Biosciences' consolidated net profit fell 73.94% to Rs 1.29 crore in Q4 FY25, despite a 3.37% increase in net sales to Rs 81.93 crore. The company aims for growth through product development and international expansion.

Insights on Hester Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.59% to 0.87% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 72.0 Cr → 76.29 Cr (in ₹), with an average increase of 5.6% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.73% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.9% return, outperforming this stock by 50.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.7% return, outperforming this stock by 176.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, HESTERBIO stock has moved down by -25.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 45.65% to 45.38% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 11.66 Cr → 1.29 Cr (in ₹), with an average decrease of 88.9% per quarter

About Hester Biosciences Ltd

Hester Pharmaceutical (HPL), established as a private limited company in April 1987 and transitioning to a public limited company in November of 1993, offers a range of veterinary and pharmaceutical products, such as animal health products, poultry vaccines, and laboratory kits and reagents. Furthermore, it markets the veterinary products of up to 10 international companies, including Ghen Corporation (Japan), Maine Biological Laboratories (US), Idexx Corporation (US), and Biogal Galed Laboratories (Israel). Entering the production of veterinary vaccines in vials, HPL also has technical collaborations with Maine Biological Laboratories and Ghen Corporation, and has since received licenses for producing an additional 10 poultry vaccines. To facilitate increased production, HPL has signed a manufacturing agreement with Sinsui Inc. for the production of additional poultry vaccines. Overall, HPL has continued to grow in the years since it was first established.

Revenue: ₹81.93Cr as on March 2025 (Q1 25)
Net Profit: ₹1.54Cr as on March 2025 (Q1 25)
Listing date: 13 Mar, 2015
OrganisationHester Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Hester Biosciences Ltd

Check out the Mutual Funds with significant holdings in Hester Biosciences Ltd.

FAQs

What is Hester Biosciences Ltd price today?

Hester Biosciences Ltd share price today stands at ₹1768.6, Open: ₹1749, Previous Close: ₹1747.6, High: ₹1795, Low: ₹1732.7, 52 Week High: ₹3379, 52 Week Low: ₹1242.95.

How to Buy Hester Biosciences Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Hester Biosciences Ltd shares

What are today's traded volumes of Hester Biosciences Ltd?

Today's traded volume of Hester Biosciences Ltd(HESTERBIO) is 4,563.00.

What is today's market capitalisation of Hester Biosciences Ltd?

Today's market capitalisation of Hester Biosciences Ltd(HESTERBIO) is ₹1,486.66 Cr.

What is the 52 Week High and Low Range of Hester Biosciences Ltd?

Hester Biosciences Ltd (HESTERBIO)
Price
52 Week High
₹3379
52 Week Low
₹1242.95

How much percentage Hester Biosciences Ltd is down from its 52 Week High?

Hester Biosciences Ltd (HESTERBIO) share price is ₹1768.6. It is down -47.66% from its 52 Week High price of ₹3379

How much percentage Hester Biosciences Ltd is up from its 52 Week low?

Hester Biosciences Ltd (HESTERBIO) share price is ₹1768.6. It is up 42.29% from its 52 Week Low price of ₹1242.95